Free Trial

Myriad Genetics (MYGN) SEC Filings & 10K Form

$28.60
+0.70 (+2.51%)
(As of 04:37 PM ET)

Recent Myriad Genetics SEC Filings

DateFilerForm TypeView
09/16/2024
1:30 PM
Ancona Margaret (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:09 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:11 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
2:26 PM
Muzzey Dale (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
9:05 AM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
4:48 PM
Dreismann Heinrich (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
1:52 PM
Dreismann Heinrich (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
6:51 PM
Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:38 PM
Myriad Genetics (Issuer)
Reitan Colleen F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:43 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
3:33 PM
Fox Jennifer Lynne (Reporting)
Myriad Genetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
9:11 AM
Myriad Genetics (Subject)
Reitan Colleen F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:48 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:16 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:38 PM
Kumar Rashmi (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
1:46 PM
Kumar Rashmi (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
3:27 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
7:22 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/04/2024
4:57 PM
Myriad Genetics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
9:32 AM
Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:48 PM
Myriad Genetics (Subject)
SPIEGELMAN DANIEL K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
4:48 PM
Myriad Genetics (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:49 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:24 PM
DIAZ PAUL J (Reporting)
Myriad Genetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
11:14 AM
Myriad Genetics (Subject)
Newcomer Lee Nisley (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
7:14 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2024
3:31 PM
Myriad Genetics (Filer)
Form DEF 14A
04/17/2024
3:31 PM
Myriad Genetics (Filer)
Form DEFA14A
04/17/2024
3:33 PM
Myriad Genetics (Filer)
Form ARS
04/15/2024
3:25 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:49 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:39 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Myriad Genetics (Subject)
Form SC 13G
03/04/2024
3:18 PM
Myriad Genetics (Issuer)
Solaiman Shereen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:31 AM
Myriad Genetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
7:24 AM
Camber Capital Management LP (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/29/2024
3:21 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/29/2024
3:27 PM
Leffler Scott J. (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
12:20 PM
Myriad Genetics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/23/2024
3:31 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Myriad Genetics (Subject)
Form SC 13G/A
[Urgent] Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.
01/16/2024
8:00 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
4:52 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
7:30 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
5:34 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
5:41 PM
Myriad Genetics (Issuer)
Raha Samraat S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:19 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
3:31 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
5:02 AM
Myriad Genetics (Filer)
Form 424B5
11/08/2023
8:16 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
7:30 AM
Myriad Genetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
3:05 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
4:12 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
8:00 PM
Myriad Genetics (Subject)
Riggsbee Richard Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2023
8:00 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
3:34 PM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
3:17 PM
Myriad Genetics (Issuer)
Wong Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:14 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Myriad Genetics (Subject)
Form SC 13G
10/11/2023
8:00 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
3:15 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:17 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:19 PM
Lambert Nicole (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:21 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:22 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
7:30 AM
Myriad Genetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
3:30 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
3:32 PM
Myriad Genetics (Issuer)
Riggsbee Richard Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
3:18 PM
Muzzey Dale (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
3:21 PM
Haas Kevin Richard (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
3:27 PM
Lambert Nicole (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:26 PM
Myriad Genetics (Issuer)
Verratti Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:31 PM
Ancona Margaret (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:33 PM
Munk Natalie (Reporting)
Myriad Genetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MYGN) was last updated on 9/17/2024 by MarketBeat.com Staff
From Our Partners